NCT03776019 is a NA clinical trial of AVWF device in Pain, sponsored by Klinikum Klagenfurt am Wörthersee.

Who is sponsoring NCT03776019?

NCT03776019 is sponsored by Klinikum Klagenfurt am Wörthersee.

What drugs are being tested in NCT03776019?

Interventions in NCT03776019: AVWF device.

What condition does NCT03776019 study?

NCT03776019 studies Pain, Stress.

Is NCT03776019 still recruiting?

NCT03776019 is currently completed. Last updated 9 September 2020.

Last reviewed 2020-09-09 · How we verify

NCT03776019

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of Audio-Visual-Perception-Enhancement (AVWF®) Method in Chronic Pain Patients

Completed NA Last updated 9 September 2020

What this trial tests

NA trial testing AVWF device in Pain in 57 participants. Completed in 20 December 2019.

Timeline

15 February 2019

Primary endpoint
20 December 2019

20 December 2019

Quick facts

Lead sponsor	Klinikum Klagenfurt am Wörthersee
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	57
Start date	15 February 2019
Primary completion	20 December 2019
Estimated completion	20 December 2019
Sites	1 location across Austria

Drugs / interventions tested

AVWF device

Conditions studied

Pain — all drugs for Pain →
Stress — all drugs for Stress →

Sponsor

Klinikum Klagenfurt am Wörthersee

Who can join

Adults 18 to 99, any sex, with Pain or Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It is anticipated that Audio-Visual-Perception-Enhancement (AVWF®) method leads to pain reduction and a decrease of inflammatory markers in chronic pain patients. Also an improvement of quality of life, self-perceived disability and depression in chronic pain patients is expected.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pain

Currently open trials in the same condition.

NCT07533409 — Tactile and Pain Sensory Thresholds and Hand Grip Strength · recruiting
NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
NCT07487610 — Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older · recruiting
NCT07454993 — The Effect of Music During Colonoscopy · NA · recruiting

Other Klinikum Klagenfurt am Wörthersee trials

Trials by the same sponsor.

NCT05257655 — Ganglionic Local Opioid Analgesia at the Ganglion Cervicale Superius · NA · completed
NCT06174324 — Visual Field Progression and RNFL Change After PreserFlo MicroShunt Implantation · unknown
NCT04168320 — SBRT-based PArtial Tumor Irradiation of HYpoxic Segment · Phase 1 · terminated
NCT06160960 — Influence of Pupillary Behavior During Eye Surgery on Morphological and Functional Outcome · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03776019 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Klinikum Klagenfurt am Wörthersee
Last refreshed: 9 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03776019.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing